[HTML][HTML] Regulation of skin barrier function via competition between AHR axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 axis: pathogenic and therapeutic implications in …
M Furue - Journal of Clinical Medicine, 2020 - mdpi.com
Atopic dermatitis (AD) is characterized by skin inflammation, barrier dysfunction, and chronic
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …
Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic …
M Furue - Journal of Clinical Medicine, 2020 - europepmc.org
Atopic dermatitis (AD) is characterized by skin inflammation, barrier dysfunction, and chronic
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …
Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic …
M Furue - Journal of Clinical Medicine, 2020 - hero.epa.gov
Atopic dermatitis (AD) is characterized by skin inflammation, barrier dysfunction, and chronic
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …
Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic …
M Furue - Journal of Clinical Medicine, 2020 - cir.nii.ac.jp
抄録< jats: p> Atopic dermatitis (AD) is characterized by skin inflammation, barrier
dysfunction, and chronic pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody …
dysfunction, and chronic pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody …
Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic …
M Furue - Journal of Clinical Medicine, 2020 - search.proquest.com
Atopic dermatitis (AD) is characterized by skin inflammation, barrier dysfunction, and chronic
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …
[HTML][HTML] Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications …
M Furue - Journal of Clinical Medicine, 2020 - ncbi.nlm.nih.gov
Atopic dermatitis (AD) is characterized by skin inflammation, barrier dysfunction, and chronic
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …
Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic …
M Furue - Journal of clinical medicine, 2020 - pubmed.ncbi.nlm.nih.gov
Atopic dermatitis (AD) is characterized by skin inflammation, barrier dysfunction, and chronic
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …
[PDF][PDF] Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4-JAK-STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in …
M Furue - J. Clin. Med, 2020 - pdfs.semanticscholar.org
Atopic dermatitis (AD) is characterized by skin inflammation, barrier dysfunction, and chronic
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …
Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic …
M Furue - Journal of Clinical Medicine, 2020 - search.ebscohost.com
Atopic dermatitis (AD) is characterized by skin inflammation, barrier dysfunction, and chronic
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …
pruritus. As the anti-interleukin-4 (IL-4) receptor α antibody dupilumab improves all three …